161 related articles for article (PubMed ID: 13318)
1. Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems.
Scatton B; Boireau A; Garret C; Glowinski J; Julou L
Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):169-75. PubMed ID: 13318
[No Abstract] [Full Text] [Related]
2. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
Julou L; Scatton B; Glowinski J
Adv Biochem Psychopharmacol; 1977; 16():617-24. PubMed ID: 18904
[No Abstract] [Full Text] [Related]
3. Inhibition of striatal dopamine synthesis in rats injected chronically with neuroleptics in their early life.
Velley L; Blanc G; Tassin JP; Thierry AM; Glowinski J
Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(1):97-102. PubMed ID: 240129
[TBL] [Abstract][Full Text] [Related]
4. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Nissbrandt H; Engberg G; Pileblad E
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
[TBL] [Abstract][Full Text] [Related]
5. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
Glowinski J
Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
[No Abstract] [Full Text] [Related]
6. Barbiturates and meprobamate: decreases in cathecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress.
Lidbrink P; Corrodi H; Fuxe K; Olson L
Brain Res; 1972 Oct; 45(2):507-24. PubMed ID: 4404488
[No Abstract] [Full Text] [Related]
7. On the significance of the increase in homovanillic acid (HVA) caused by antipsychotic drugs in corpus striatum and limbic forebrain.
Stawarz RJ; Hill H; Robinson SE; Setler P; Dingell JV; Sulser F
Psychopharmacologia; 1975 Aug; 43(2):125-30. PubMed ID: 242028
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems.
Healy DJ; Meador-Woodruff JH
Brain Res; 1996 Feb; 708(1-2):38-44. PubMed ID: 8720857
[TBL] [Abstract][Full Text] [Related]
9. Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions.
Tolbert LC; Thomas TN; Middaugh LD; Zemp JW
Brain Res Bull; 1979; 4(1):43-8. PubMed ID: 572739
[TBL] [Abstract][Full Text] [Related]
10. Temporal changes in catecholamine synthesis of rat forebrain structures after axotomy.
Kehr W
J Neural Transm; 1974; 35(4):307-17. PubMed ID: 4436670
[No Abstract] [Full Text] [Related]
11. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.
Lategan AJ; Marien MR; Colpaert FC
Life Sci; 1992; 50(14):995-9. PubMed ID: 1372673
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic drugs and catecholamine synapses. Summary of the session.
Andén NE
J Psychiatr Res; 1974; 11():97-104. PubMed ID: 4156797
[No Abstract] [Full Text] [Related]
13. [Stereotyped behavior and the nigro-strio-nigral system].
Arushanian EB
Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
[No Abstract] [Full Text] [Related]
14. Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections.
Seiden LS; Commins DL; Vosmer G; Axt K; Marek G
Ann N Y Acad Sci; 1988; 537():161-72. PubMed ID: 3059922
[TBL] [Abstract][Full Text] [Related]
15. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
Roger LJ; Breese GR; Morell P
Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
[TBL] [Abstract][Full Text] [Related]
17. Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway.
Oberlander C; Euvrard C; Dumont C; Boissier JR
Eur J Pharmacol; 1979 Dec; 60(2-3):163-70. PubMed ID: 575095
[No Abstract] [Full Text] [Related]
18. [Fluorescence of dopamine terminals in rat brain during reproduction of conditioned defense reactions].
Spiridonov VK
Neirofiziologiia; 1979; 11(2):171-3. PubMed ID: 440491
[No Abstract] [Full Text] [Related]
19. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptors.
Meltzer HY; Simonovic M; Fang V; Piyakalamala S; Young M
Life Sci; 1978 Aug; 23(6):605-9. PubMed ID: 29199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
